课题基金 / 基金详情

CD4 T cell plasticity and residual immune dysregulation syndrome in the new ART era

CD4 T cell plasticity and residual immune dysregulation syndrome in the new ART era
新ART时代CD4 T细胞可塑性与残余免疫失调综合征
批准号：
310126
负责人：
Kaufmann Daniel E
金额：
$27.32万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2017-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=310126&lang=en
关键词：
Art Cd4 T Cell Cd4 T Cell Plasticity Chronic Inflammation Gut-Associated Lymphoid Tissue Hiv Immune Dysfunction Immune Restoration

项目摘要

项目成果

Kaufmann Daniel E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antiviral therapy (ART) that blocks replication of HIV has resulted in a dramatic improvement in the quality of life for people living with HIV/AIDS. Specific white cells called CD4 T cells that recognize microbes and viruses and act as coordinators of th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunovirological determinants of breakthrough COVID-19 disease in vaccinated or previously infected individuals
COVID-19 Variant Supplement - Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease
Early immune predictors of sustained SARS-CoV-2 antibody responses after COVID-19 disease
The molecular basis of persistent HIV-specific CD4 T cell dysfunction
海外基金